Lactose (India) Ltd | 149 Cr. | 118 | 247/84.3 | 33.8 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.96 Cr. | 2.07 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,597 Cr. | 422 | 434/192 | 103 | 22.8 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 40.4 Cr. | 54.5 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 30.7 Cr. | 20.9 | 29.1/17.0 | 32.0 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 61.1 Cr. | 81.1 | 142/78.9 | 16.1 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 53,072 Cr. | 1,881 | 2,286/1,275 | 39.8 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 293 Cr. | 12.9 | 23.8/10.8 | 17.8 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 700 Cr. | 1,482 | 1,526/635 | 29.8 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 105 Cr. | 21.0 | 32.0/15.0 | 32.2 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 791 Cr. | 269 | 449/219 | 7.56 | 123 | 0.93 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 12.7 Cr. | 5.09 | 9.28/2.11 | 7.20 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 387 Cr. | 399 | 477/112 | 62.4 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,830 Cr. | 1,110 | 1,584/1,045 | 47.1 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 71.6 Cr. | 0.35 | 1.24/0.35 | 4.71 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 54.8 Cr. | 22.8 | 26.3/6.40 | 56.5 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 9.71 Cr. | 9.61 | 17.2/9.50 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
Coral Laboratories Ltd | 190 Cr. | 533 | 925/443 | 10.3 | 563 | 0.28 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 66.5 Cr. | 66.5 | 71.2/26.1 | 170 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.4 Cr. | 42.5 | 88.7/37.9 | 40.5 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 14.1 Cr. | 5.65 | 5.65/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.8 Cr. | 125 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 31.9 Cr. | 58.3 | 58.3/9.41 | 354 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 35.1 Cr. | 46.5 | 80.0/0.00 | 49.4 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 6.80 Cr. | 22.7 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,398 Cr. | 657 | 1,028/464 | 31.8 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 89.5 Cr. | 20.7 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.3 Cr. | 22.3 | 43.7/17.4 | 49.2 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 269 Cr. | 467 | 524/241 | 28.2 | 119 | 0.96 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 62.4 Cr. | 43.4 | 62.6/31.6 | 56.2 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 65,906 Cr. | 1,125 | 1,500/994 | 19.4 | 557 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 135 Cr. | 216 | 303/170 | 195 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 794 Cr. | 79.2 | 123/74.0 | 17.2 | 32.5 | 1.89 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 41.4 Cr. | 31.7 | 50.5/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
Acutaas Chemicals Ltd | 12,255 Cr. | 1,497 | 1,530/727 | 64.8 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.10 Cr. | 0.62 | 1.45/0.62 | 82.0 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 253 Cr. | 33.0 | 68.0/30.0 | 13.5 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.48 Cr. | 16.2 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 143 Cr. | 6.05 | 6.57/2.82 | 259 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 63,952 Cr. | 30,095 | 37,000/25,260 | 44.0 | 1,992 | 1.58 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,484 Cr. | 826 | 972/550 | 28.1 | 220 | 0.61 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 241 Cr. | 85.2 | 85.2/31.3 | 58.0 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,516 Cr. | 1,489 | 1,577/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 22,235 Cr. | 1,368 | 1,870/1,006 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 814 Cr. | 247 | 330/154 | 18.9 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
Venus Remedies Ltd | 604 Cr. | 452 | 568/270 | 12.9 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,314 Cr. | 471 | 950/456 | 26.5 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,590 Cr. | 1,125 | 1,693/991 | 23.6 | 754 | 0.89 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,19,195 Cr. | 3,522 | 3,790/2,886 | 59.0 | 224 | 0.91 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,147 Cr. | 125 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,543 Cr. | 16.4 | 24.0/14.1 | 27.1 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 33,169 Cr. | 867 | 1,360/856 | 94.3 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,461 Cr. | 196 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,96,946 Cr. | 1,654 | 1,924/1,547 | 34.6 | 301 | 0.97 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,624 Cr. | 581 | 886/441 | 107 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,429 Cr. | 274 | 350/175 | 34.6 | 75.9 | 0.15 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 347 Cr. | 1,147 | 1,690/956 | 20.1 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 6,904 Cr. | 353 | 502/265 | 53.7 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 5,261 Cr. | 209 | 232/111 | 174 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 10,884 Cr. | 4,726 | 7,090/4,146 | 30.5 | 340 | 2.48 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,811 Cr. | 2,304 | 2,914/1,772 | 36.8 | 321 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,178 Cr. | 6,132 | 6,739/4,863 | 33.9 | 323 | 2.04 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 158 Cr. | 44.7 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 24,658 Cr. | 5,390 | 5,993/3,701 | 36.5 | 922 | 0.65 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 126 Cr. | 102 | 348/81.0 | 8.87 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,724 Cr. | 445 | 582/278 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,674 Cr. | 724 | 1,998/604 | 43.1 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,983 Cr. | 16,355 | 18,100/10,060 | 159 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 305 Cr. | 13.6 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 14,503 Cr. | 810 | 1,505/660 | 8.54 | 425 | 0.74 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,647 Cr. | 48.3 | 94.5/41.7 | 28.6 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 8,207 Cr. | 181 | 359/162 | 23.4 | 54.4 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 111 Cr. | 70.1 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
Lyka Labs Ltd | 339 Cr. | 94.9 | 177/90.2 | 45.2 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 88,488 Cr. | 1,937 | 2,403/1,774 | 23.9 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,049 Cr. | 524 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
Laurus Labs Ltd | 47,394 Cr. | 878 | 944/440 | 93.0 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 902 Cr. | 870 | 1,235/596 | 20.8 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 151 Cr. | 70.2 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 804 Cr. | 167 | 329/154 | 23.0 | 107 | 1.80 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 623 Cr. | 356 | 500/265 | 22.2 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,177 Cr. | 1,078 | 1,310/802 | 35.4 | 393 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,981 Cr. | 1,659 | 1,998/1,303 | 37.9 | 221 | 0.93 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,414 Cr. | 212 | 328/175 | 33.2 | 36.1 | 1.18 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,136 Cr. | 1,306 | 1,758/1,168 | 37.0 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,821 Cr. | 96.1 | 127/57.5 | 26.8 | 57.5 | 0.83 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 756 Cr. | 103 | 134/67.2 | 34.3 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
Indoco Remedies Ltd | 2,720 Cr. | 295 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 2,938 Cr. | 238 | 465/236 | 46.4 | 102 | 0.59 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,464 Cr. | 1,720 | 2,786/1,243 | 38.9 | 369 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,663 Cr. | 365 | 504/285 | 59.9 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
Granules India Ltd | 13,832 Cr. | 570 | 628/412 | 29.0 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 53,415 Cr. | 1,893 | 2,286/1,275 | 40.1 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,817 Cr. | 2,764 | 3,516/1,921 | 49.4 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,646 Cr. | 1,921 | 2,131/1,200 | 27.9 | 592 | 0.94 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,101 Cr. | 436 | 570/359 | 26.4 | 140 | 1.15 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 21,786 Cr. | 1,599 | 1,910/1,097 | 56.3 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,03,267 Cr. | 1,237 | 1,406/1,020 | 18.2 | 402 | 0.65 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,375 Cr. | 279 | 322/169 | 36.8 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,25,389 Cr. | 1,552 | 1,612/1,310 | 23.2 | 386 | 0.84 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,970 Cr. | 1,970 | 2,641/1,551 | 26.5 | 375 | 0.30 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 372 Cr. | 126 | 203/95.6 | 183 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,617 Cr. | 153 | 191/105 | 15.2 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 66.9 Cr. | 41.1 | 78.0/40.0 | 24.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 47,041 Cr. | 352 | 406/291 | 130 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,731 Cr. | 1,715 | 2,215/1,430 | 37.8 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
Bal Pharma Ltd | 131 Cr. | 82.1 | 141/76.3 | 18.2 | 48.6 | 1.46 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 362 Cr. | 153 | 179/67.8 | 35.9 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,804 Cr. | 9,122 | 10,691/6,220 | 108 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,045 Cr. | 707 | 843/544 | 37.5 | 113 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 186 Cr. | 88.5 | 137/85.0 | 7.07 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 65,677 Cr. | 5,493 | 6,300/4,492 | 28.9 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,003 Cr. | 916 | 1,202/725 | 30.4 | 264 | 1.20 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 450 Cr. | 789 | 1,540/763 | 71.6 | 688 | 0.63 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 29,885 Cr. | 2,392 | 3,395/2,022 | 32.1 | 303 | 1.17 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,426 Cr. | 306 | 518/258 | 25.0 | 127 | 1.70 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,611 Cr. | 502 | 575/312 | 25.8 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 18,850.22 Cr | 1,169.52 | | 49.77 | 192.71 | 0.34% | 16.15% | 14.90% | 6.18 |